These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 39337383

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mitochondrial Transplantation Therapy Ameliorates Muscular Dystrophy in mdx Mouse Model.
    Dubinin MV, Mikheeva IB, Stepanova AE, Igoshkina AD, Cherepanova AA, Semenova AA, Sharapov VA, Kireev II, Belosludtsev KN.
    Biomolecules; 2024 Mar 07; 14(3):. PubMed ID: 38540736
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Alisporivir Improves Mitochondrial Function in Skeletal Muscle of mdx Mice but Suppresses Mitochondrial Dynamics and Biogenesis.
    Dubinin MV, Starinets VS, Talanov EY, Mikheeva IB, Belosludtseva NV, Belosludtsev KN.
    Int J Mol Sci; 2021 Sep 10; 22(18):. PubMed ID: 34575944
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle.
    Kennedy TL, Moir L, Hemming S, Edwards B, Squire S, Davies K, Guiraud S.
    Skelet Muscle; 2017 Oct 24; 7(1):22. PubMed ID: 29065908
    [Abstract] [Full Text] [Related]

  • 10. Impaired mitochondrial oxidative phosphorylation in skeletal muscle of the dystrophin-deficient mdx mouse.
    Kuznetsov AV, Winkler K, Wiedemann FR, von Bossanyi P, Dietzmann K, Kunz WS.
    Mol Cell Biochem; 1998 Jun 24; 183(1-2):87-96. PubMed ID: 9655182
    [Abstract] [Full Text] [Related]

  • 11. Early myopathy in Duchenne muscular dystrophy is associated with elevated mitochondrial H2 O2 emission during impaired oxidative phosphorylation.
    Hughes MC, Ramos SV, Turnbull PC, Rebalka IA, Cao A, Monaco CMF, Varah NE, Edgett BA, Huber JS, Tadi P, Delfinis LJ, Schlattner U, Simpson JA, Hawke TJ, Perry CGR.
    J Cachexia Sarcopenia Muscle; 2019 Jun 24; 10(3):643-661. PubMed ID: 30938481
    [Abstract] [Full Text] [Related]

  • 12. Defects in mitochondrial localization and ATP synthesis in the mdx mouse model of Duchenne muscular dystrophy are not alleviated by PDE5 inhibition.
    Percival JM, Siegel MP, Knowels G, Marcinek DJ.
    Hum Mol Genet; 2013 Jan 01; 22(1):153-67. PubMed ID: 23049075
    [Abstract] [Full Text] [Related]

  • 13. Striated muscle activator of Rho signalling (STARS) overexpression in the mdx mouse enhances muscle functional capacity and regulates the actin cytoskeleton and oxidative phosphorylation pathways.
    Sadler KJ, Gatta PAD, Naim T, Wallace MA, Lee A, Zaw T, Lindsay A, Chung RS, Bello L, Pegoraro E, Lamon S, Lynch GS, Russell AP.
    Exp Physiol; 2021 Jul 01; 106(7):1597-1611. PubMed ID: 33963617
    [Abstract] [Full Text] [Related]

  • 14. Uridine Administration Promotes Normalization of Heart Mitochondrial Function in Dystrophin-Deficient Mice and Decreases Tissue Fibrosis.
    Dubinin MV, Belosludtseva NV, Mikheeva IB, Chelyadnikova YA, Penkina DK, Vafina AB, Starinets VS, Kireev II, Belosludtsev KN.
    Bull Exp Biol Med; 2023 Nov 01; 176(1):54-59. PubMed ID: 38091140
    [Abstract] [Full Text] [Related]

  • 15. Attempting to Compensate for Reduced Neuronal Nitric Oxide Synthase Protein with Nitrate Supplementation Cannot Overcome Metabolic Dysfunction but Rather Has Detrimental Effects in Dystrophin-Deficient mdx Muscle.
    Timpani CA, Trewin AJ, Stojanovska V, Robinson A, Goodman CA, Nurgali K, Betik AC, Stepto N, Hayes A, McConell GK, Rybalka E.
    Neurotherapeutics; 2017 Apr 01; 14(2):429-446. PubMed ID: 27921261
    [Abstract] [Full Text] [Related]

  • 16. Mitochondrial hydrogen sulfide supplementation improves health in the C. elegans Duchenne muscular dystrophy model.
    Ellwood RA, Hewitt JE, Torregrossa R, Philp AM, Hardee JP, Hughes S, van de Klashorst D, Gharahdaghi N, Anupom T, Slade L, Deane CS, Cooke M, Etheridge T, Piasecki M, Antebi A, Lynch GS, Philp A, Vanapalli SA, Whiteman M, Szewczyk NJ.
    Proc Natl Acad Sci U S A; 2021 Mar 02; 118(9):. PubMed ID: 33627403
    [Abstract] [Full Text] [Related]

  • 17. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
    Lindsay A, McCourt PM, Karachunski P, Lowe DA, Ervasti JM.
    Free Radic Biol Med; 2018 Dec 02; 129():364-371. PubMed ID: 30312761
    [Abstract] [Full Text] [Related]

  • 18. Deletion of Galgt2 (B4Galnt2) reduces muscle growth in response to acute injury and increases muscle inflammation and pathology in dystrophin-deficient mice.
    Xu R, Singhal N, Serinagaoglu Y, Chandrasekharan K, Joshi M, Bauer JA, Janssen PM, Martin PT.
    Am J Pathol; 2015 Oct 02; 185(10):2668-84. PubMed ID: 26435413
    [Abstract] [Full Text] [Related]

  • 19. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE, Trieu J, Chee A, Naim T, Gehrig SM, Lamon S, Angelini C, Russell AP, Lynch GS.
    Exp Physiol; 2014 Apr 02; 99(4):675-87. PubMed ID: 24443351
    [Abstract] [Full Text] [Related]

  • 20. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
    Siemionow M, Langa P, Brodowska S, Kozlowska K, Zalants K, Budzynska K, Heydemann A.
    Stem Cell Rev Rep; 2022 Dec 02; 18(8):2872-2892. PubMed ID: 35590083
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.